Healthcare Innovation CSR News

Putting Purpose Into Action: A Message From Our CEO

It's never been clearer: our future depends on companies that not only innovate boldly, but ones that act with integrity.
Article

Over the past months, we’ve seen ties between health, progress, and prosperity strain in real time due to the hardships brought on by the pandemic. Life as we know it changed dramatically, as did the role of the private sector in many ways.

Dow Awarded 2020 NSC Green Cross Safety Innovation Award

Press Release

MIDLAND, Mich., October 13, 2020 /3BL Media/ – Dow (NYSE: DOW) announced recently that it has been awarded the 2020 National Safety Council (NSC) Green Cross for Safety® Innovation Award.

Dow received the NSC Green Cross for Safety® Innovation Award during the 2020 Green Cross for Safety Awards virtual celebration on October 1 for its Aerial Lift Safety Project, for approaching a lasting challenge and developing a transformative response to the problem.

Tork® Site Safety Guide Shares Hygiene and Safety Recommendations for Manufacturers

Hygiene and health company Essity has developed the Tork Site Safety Guide for Manufacturing to share best practices
Press Release

The Science & Art of Goal Setting: Announcing Johnson & Johnson's New Climate Goals

by Paulette Frank, Worldwide Vice President, Environmental Health, Safety & Sustainability at Johnson & Johnson
Blog

I am so incredibly proud to have had the privilege to share Johnson & Johnson’s new climate goals during this Climate Week NYC 2020.

CRB's SlateXpace™ Gives Cell and Gene Therapy Clients New Flexibility, Control Over Manufacturing Needs To Support Highly Complex Product Pipelines

CRB, a leader in the design and construction of biotech manufacturing facilities, creates SlateXpace – a multimodal facility solution that delivers unmatched industry speed, flexibility and adaptability for the advanced therapy market
Press Release

SAN DIEGO, Calif., Sept. 30, 2020 /3BL Media/ – Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
Press Release

NEW BRUNSWICK, N.J., September 28, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.

The Next Phase of Our COVID-19 Vaccine Development

by Alex Gorsky Chairman of the Board and Chief Executive Officer, Johnson & Johnson
Blog

It’s hard to believe that just six months have passed since our scientists identified Janssen’s lead COVID-19 vaccine candidate. We couldn’t have predicted all the changes that have happened since. Two things, however, have been constant: COVID-19 continues to be a devastating pandemic, and Johnson & Johnson has been working around the clock on a potential solution.

The Road to a Vaccine, Season 2, Ep. 7: Is It Really Safe for Schools to Be Open Right Now?

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

Johnson & Johnson Consumer Health Commits $800 Million Through 2030 to Make Its Products More Sustainable for a Healthier Planet

Summary: 

As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.

Article

As part of its new Healthy Lives Mission, the company's iconic consumer brands will aim to use 100% recyclable, reusable or compostable plastic packaging and certified/post-consumer recycled paper- and pulp-based packaging. Learn more about the unique ways the investment will improve the health of people and the earth.

Pages

Subscribe to Healthcare Innovation